CHI, Cambridge Healthtech Institute

Conference Menu

Overview

PDF Download

Register

Hotel & Travel

Press Pass

Request Brochure

Send to a Colleague

Sponsor/Exhibit

Corporate Sponsor:

Corporate Support Sponsor:

Lead Sponsoring Publication:

Sponsoring Publications:

Web Partner:

Register by November 4, 2005 and save $300

Overview

This event will Specifically Address

The Impact of the New Reality, including Outsourcing, on Portfolio Strategies
Portfolio, Project Management and Resource Management for Enhanced Competitiveness
Improving Understanding and Acceptance of Resource Management throughout the Company
Proactively Managing Risk in R&D
Lessons in Portfolio and Resource Management from the Aerospace and Automotive Industries
Aligning Portfolio Priorities with Resource Capacity and Business Strategies
Strategies for Improving Resource Management to Increase R&D Performance

Thursday, December 1

8:00 Pre-Conference Tutorial Registration

8:30 Pre-Conference Tutorial
Presenters: Jan Malek; Andrew Chadwick;
Stephen Morehouse; and Hein Smit Sibinga, PA Consulting
Understanding and Managing Risk in
Pharma and Biotech R&D
Uncertainty and risk are, of course, inherent in all pharmaceutical and biotech R&D efforts. R&D organizations can either be confounded by it or they can take proactive steps to understand and manage it. This workshop will illustrate practical examples of how Project, Resource and Portfolio Managers can keep R&D programs out of trouble by understanding and proactively managing risk. We will discuss three different perspectives on risk and three different risk-management approaches:

• To get the most bang for you bucks, do you want "a portfolio of good projects" or "a good portfolio of projects"? A discussion of how portfolio dynamics and project interdependencies can confound the unwary.

• Why projects go wrong, how to resuscitate them and how to avoid getting in trouble in the first place. A review of PA's integrated Program management approach, which focuses on the identification and management of risks, understanding of organizational preparedness to execute projects according to plan and program decision-making. We will use case studies to illustrate how troubled programs were resuscitated using this approach.

• Do all the tests that you run generate information that is commensurate in value with their respective costs and elapsed times? A demo of a knowledge-guided planning model that enables R&D organizations to manage pipeline quality and attrition more purposefully. Specifically, we will show how R&D organizations can save time and effort by dispensing with testing activities that do not contribute critical new knowledge about compounds or series.

11:30 Pre-Conference Tutorial ends

Sponsored by

12:30 Main Conference Registration

1:00 Chair's Opening Remarks

1:15 Optimizing Productivity in a Matrix Structure
• A 30 year decline in productivity in the industry highlights the need for optimization in
structural and operational aspects
• Roles and responsibilities in a functioning matrix organization
• Alignment between matrix management principles, development standards, and functional
operating norms
• Achievement of highest levels of accountability and performance
Dr. Juergen Krause, Vice President, R&D Strategy and Operations/Drug Development Management, Millennium Pharmaceuticals, Inc.

2:00 Balancing Portfolio Priorities and Resources:
The Role of Portfolio and Project Management
• Organizational challenges that emphasize the importance of Priorities and Resource
Management during rapid phases of organizational growth
• Overview of a process to align priorities and resources
• Roles and responsibilities in the portfolio management process
• Information needs of different stakeholder groups
Dr. Marc Watrous, Senior Director, Product Portfolio Management, Genentech Inc.

2:45 Networking and Refreshment Break

3:15 Roundtable Discussions

Table 1. Making Go/No-Go Decisions on Backups to Killed Projects
Mr. John Guedes, Group Director, Resource Management, Bristol-Myers
Squibb Co.

Table 2. Overcoming Objections to Change: Gaining Buy-In for Resource
Management from Scientists
Mr. Michael J. DeFelice, M.S., M.B.A, Director, Resource & Research Planning, Worldwide OTC Development, Merck Global R&D Administration

Table 3. Reducing Demand Variability: Strategic & Tactical Approaches
Moderator to be Announced

4:45 Networking Reception

5:45 Close of Day One

“Can save you years of headaches. A ‘must’ for all resource/portfolio managers.”
Attila Aranyos, Senior Project Manager, Strategic Products Development, Merial

“If you're implementing systems, this is the place to be. One big room of like-minded individuals. Great brain power!”
Jennifer Goldman, Business Manager, Experimental Medicine, Wyeth

Friday, December 2

8:30 Chairperson's Remarks

8:40 Reports and Discussion from Roundtables

9:15 Off-Industry Perspective: Thermo-Nuclear Warheads + Seatbelts + Airbags =

A. One heck of a joy ride
B. Lessons for the pharma industry.
C. All of the above

Topics to be covered include:
• "How I Learned to Stop Worrying and Love the Bomb"
• Seat Belts: Why You should use them.
• Important warning about Children and airbags.
• How does this all tie to the Pharma industry?
Mr. Peter Benton, Managing Director, Sceata Technology Group, LLC

10:00 Why Do Builders Need Architects? Designing a Strategic Resource Management System for R&D
• Understanding the drivers of changing drug project resource demand: productivity,
   environment, strategy
• Optimization of long term R&D output: balancing investment in productivity initiatives with
   investment in the drug project portfolio
• Human aspects of process and organizational design: architects vs. builders, and Myers
   Briggs N vs. S types
Dr. Mellor Hennessy, Global Portfolio and Productivity Strategist, AstraZeneca

10:45 Coffee Break

11:15 Roundtable Discussions

Table 1. Outsourced Resources: Managing and Integrating into the PortfolioStrategy
Dr. Michael Myers, Director, Project Management, Eli Lilly

Table 2. Collaborating Between Projects for Effective Resource and Capacity Management
Mr. William Flounders, Senior Director, Functional Planning and Resource Management, sanofi-pasteur

Table 3. Cultural and Behavorial Challenges of Resource Management: Achieving a Portfolio Mindset at All Levels
Mrs. Pat Barrila, Portfolio Director, Oncology, Worldwide Portfolio
Management, Pfizer Global Research and Development

12:30 Luncheon Workshop	Sponsored by

1:45 Reports and Discussion from Roundtables

2:15 Improved Alignment of Initiatives and Investments Can Improve Pharma-Biotech Research Productivity

• A number of initiatives have been taken to improve R&D performance, to address
   changes in the industry, company cultures, advances in technology and
   processes for decision-making.
• Changes made in each area independently, without consideration of the
   implications for each other area, leads to misalignment.
• Alignment is continual process to assure that inter-dependencies are explicitly
   recognized and addressed.
• Approaches for achieving strategic alignment in R&D will be presented.
Dr. Bradford Kirkman-Liff, Professor of Health Policy and Biotechnology, W.P. Carey School of Business, Arizona State University

3:00 Networking and Refreshment Break

3:30 Achieving Operational Efficiencies through Effective Resource Management Using Enterprise Management Software (EMS)
• A real business need for effective Resource Management in Pharmaceutical R&D
• Strategic Resource Management and Capacity Planning at Wyeth
• Using EMS to dynamically reallocate resources across the portfolio
• Mitigation of certain risks through effective Resource Management
Dr. Krish Ghosh, MBA, Director, Project Planning and Information, Project Management, Wyeth Pharmaceuticals

4:15 Achieving Greater Efficiency in Pharma R&D Using the Baldridge Award
• Pharma's current approach to organizational improvement
• Root causes for why Pharma has not been actively using the Baldrige award
• Recommendations for responding to these root causes
Mr. John Werner, Associate Director, Project Management Operations, Pfizer, Inc.

5:00 Wrap-Up and Conclusions

5:15 Close of Executive Forum

For Sponsorship and Exhibit Opportunities
John Yurewicz, Manager of Business Development
Phone: 617.630.1383, Cell: 857-636-8188 • Email: jyurewicz@healthtech.com